Apyx Medical Company Insiders
APYX Stock | USD 1.45 0.00 0.00% |
Apyx Medical's insiders are aggressively buying. The analysis of insiders' sentiment of trading Apyx Medical stock suggests that vertually all insiders are extremely bullish at this time. Apyx Medical employs about 252 people. The company is managed by 6 executives with a total tenure of roughly 23 years, averaging almost 3.0 years of service per executive, having 42.0 employees per reported executive.
Moshe Citronowicz President Senior Vice President |
Todd Hornsby President Executive Vice President |
Apyx Medical's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
2024-08-13 | Matthew C Hill | Acquired 5336 @ 1.13 | View | ||
2023-12-12 | Matthew C Hill | Acquired 2500 @ 2.19 | View |
Monitoring Apyx Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Apyx |
Apyx Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.2183) % which means that it has lost $0.2183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1025) %, meaning that it created substantial loss on money invested by shareholders. Apyx Medical's management efficiency ratios could be used to measure how well Apyx Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.22 in 2024. Return On Capital Employed is likely to rise to -0.25 in 2024. At this time, Apyx Medical's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 8.2 M in 2024.Common Stock Shares Outstanding is likely to drop to about 22.4 M in 2024. Net Loss is likely to rise to about (19.8 M) in 2024
Apyx Medical Workforce Comparison
Apyx Medical is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,730. Apyx Medical retains roughly 252 in number of employees claiming about 15% of equities under Health Care industry.
Apyx Medical Profit Margins
The company has Profit Margin (PM) of (0.58) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.46.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.37 | 0.2698 |
|
|
Apyx Medical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apyx Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apyx Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Apyx Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Apyx Medical Notable Stakeholders
An Apyx Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Apyx Medical often face trade-offs trying to please all of them. Apyx Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Apyx Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Charles II | CEO President | Profile | |
Stavros BCom | Executive Chairman | Profile | |
Moshe Citronowicz | Senior Vice President | Profile | |
Todd Hornsby | Executive Vice President | Profile | |
Tara Semb | Treasurer CFO | Profile | |
Matthew CPA | Chief Officer | Profile |
About Apyx Medical Management Performance
The success or failure of an entity such as Apyx Medical often depends on how effective the management is. Apyx Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Apyx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Apyx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.24) | (0.22) | |
Return On Capital Employed | (0.26) | (0.25) | |
Return On Assets | (0.24) | (0.22) | |
Return On Equity | (0.70) | (0.67) |
Please note, the imprecision that can be found in Apyx Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apyx Medical. Check Apyx Medical's Beneish M Score to see the likelihood of Apyx Medical's management manipulating its earnings.
Apyx Medical Workforce Analysis
Traditionally, organizations such as Apyx Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Apyx Medical within its industry.Apyx Medical Manpower Efficiency
Return on Apyx Medical Manpower
Revenue Per Employee | 207.7K | |
Revenue Per Executive | 8.7M | |
Net Loss Per Employee | 74.8K | |
Net Loss Per Executive | 3.1M | |
Working Capital Per Employee | 228.7K | |
Working Capital Per Executive | 9.6M |
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.